NeuBase Therapeutics, Inc. Business Combination, Contingent Consideration, Liability, Current
NeuBase Therapeutics, Inc. had Business Combination, Contingent Consideration, Liability, Current of $1.54 million as of 2016-06-30, per its 10-Q filed 2016-08-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2016-12-22
- 2016-06-30: Business Combination, Contingent Consideration, Liability, Current $1.54M.
- 2015-09-30: Business Combination, Contingent Consideration, Liability, Current $2.24M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2016-06-30 | $1.54M 10-Q · filed 2016-08-09 |
| 2015-09-30 | $2.24M 10-K · filed 2016-12-22 |